Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
archive
astrazeneca
biogen
biotech
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
coronavirus
covid-19
crispr
deals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
fda
forty seven
fred hutch
general atlantic
gilead sciences
givosiran
healthcare
imara
immunocore
indiana blog main
What
ceo
covid
2
×
gilead
2
×
sciences
acquisitions
addressed
announced
answers
big
bio
collabs
cost
daniel
deal
drug
early
gilead’s
hasten
help
indicated
introduce
ipo
medicine
medicines
month
o’day
plans
positive
question
recove
remdesivir
roundup
surrounding
transformative
treatment
trials
years
Language
unset
Current search:
gilead
×
covid
×
@slashgear.com
3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
